Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) EBT Margin: 2009-2024

Historic EBT Margin for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to 47.55%.

  • Ironwood Pharmaceuticals' EBT Margin rose 3676.00% to 55.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.66%, marking a year-over-year increase of 9861.00%. This contributed to the annual value of 47.55% for FY2024, which is 31285.00% up from last year.
  • Ironwood Pharmaceuticals' EBT Margin amounted to 47.55% in FY2024, which was up 117.92% from -265.31% recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' EBT Margin ranged from a high of 61.48% in FY2022 and a low of -265.31% during FY2023.
  • Moreover, its 3-year median value for EBT Margin was 47.55% (2024), whereas its average is -52.09%.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' EBT Margin crashed by 32,678bps in 2023, and later spiked by 31,285bps in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' EBT Margin (Yearly) stood at 27.95% in 2020, then soared by 2,055bps to 48.50% in 2021, then spiked by 1,298bps to 61.48% in 2022, then plummeted by 32,678bps to -265.31% in 2023, then skyrocketed by 31,285bps to 47.55% in 2024.